Replies to post #2665 on Cdex, Inc. (fka CDEX)

[lmorovan]

Garry, it all sounds good and promising. The question is: where is the beef? Why didn't CDEX apply yet for FDA approval? Any application of the "supposed" technology will never go beyond garbage detection without FDA approval. And I don't think there is a big enough market for Valimed as is now to make any significant difference in the current status of the company with only "that" application.

I see that not a single so called "Long" ever raise the issue of the FDA approval. I do see, however, that as time passes by, more and more Longs are justifying any and all actions/inactions of the company as something positive.

It is hard for me to believe that anyone even cares whether CDEX becomes successful or not, a long as there is enough noise around to cause the price to go up and give them a chance to, finally, get out of this chicanery with as little a loss as possible. I know, and understand that investors invest to make money, not to fall in love with the stock or the company.

If I had the slightest feeling that CDEX could make it, I would encourage each and everyone of the shareholder (35,000) to even donate $100.00 each to help the company financially and make it a success, with the possible outcome of a solid share price and a promotion to a higher exchange. But I will not do it as long as I see over $3 million wasted each year, without showing any tangible product or service.

I also understand that current shareholders have no other choice but to wait things out and hope for the best. What hurts me a lot is seeing that no one prepares for the worst. And, as time is passing by, the value of the investment is continuously and consistently decreasing by many factors, including dilution, inflation, money leaking constantly through the trading of insiders, private placement investors and now, even employees. By this time, CDEX must have incurred in over $17 million in loss. $17 million! Not to mention that it ran out of Class A Common Stock, causing a reasonable need for increase of the authorized and issued shares, for more dilution.

I likewise understand that shareholders that have a substantial stake in the company will make great effort to read between the lines of every filing or article, because what the lines say is not at all encouraging.

No hyping can make CDEX successful, no bashing can make CDEX fail. It is all in the hands of a person that, for the last 3 years never fails to point out that he has very little experience in the business the company is in.

If there is anything in the "technology" it should have showed up by now in a clear and unequivocal manner. Whether the management team is qualified or not to market the products is irrelevant as long as there is no independent third party verification and validation of the "technology" and its applications. Such a validation would do more for the marketability of the company's products than the best team of managers and sales people. If a medical student working in a garage would find a cure for cancer, he would need a big security team to control the corporations and companies lining up at his door, rather than a superb marketing an sales team.

Well, that's it for now.

[Crow3]

With all the problems that CDEX has, SKIT, it is a miatake to dismiss the ultra detailed and exquisitely painful disclaimers as "everybody does it".

Sure, I have read many PRs and filing of many companies, and they all use disclaimers "safe harbor" statements.

But MP goes far beyond what is required. Clearly, he wants to avoid as much blame if he can, if he has to close the thing down. None can say that he did not warn them.

They do not have much money, and the window of opportunity to market high tech, (assuming that they have such) is very narrow. In other words, get it on the market before anyone else does.